ID1 and plasma cell myeloma: CTLs and Th1s were found to suppress myeloma growth, whereas Id-specific Th2 cells promoted it (96) – a preclinical clue in support of the contention that modulation of the Th1:Th2 axis might have therapeutic benefits in myeloma.